 |
市场调查报告书
商品编码
1898333
DNA合成市场规模、份额和成长分析（按产品、类型、方法、应用、最终用户和地区划分）—产业预测，2026-2033年DNA Synthesis Market Size, Share, and Growth Analysis, By Product (Instruments, Reagents & Consumables), By Type (Oligonucleotide Synthesis, Gene Synthesis), By Method, By Application, By End-user, By Region - Industry Forecast 2026-2033 |
||||||
预计到 2024 年，DNA 合成市场价值将达到 53.1 亿美元，到 2025 年将成长至 61.9 亿美元，到 2033 年将成长至 210 亿美元，在预测期（2026-2033 年）内复合年增长率为 16.5%。
在製药、生物技术和基因研究等关键应用领域的推动下，DNA合成市场正经历强劲成长。生物技术公司和研究人员越来越依赖DNA合成服务来创建客製化的DNA序列，用于药物开发和基因工程等领域。推动市场扩张的关键因素包括合成生物学工具需求的成长、个人化医疗的蓬勃发展以及基因编辑技术的持续进步。此外，DNA合成能够实现快速原型製作和实验，从而促进创新并加速科学发现。随着生物技术和医疗保健产业的进步，DNA合成有望在基因组学和分子生物学的发展中发挥关键作用，并影响这些领域的未来发展。
DNA合成市场驱动因素
推动DNA合成市场成长的关键因素是基因工程技术的不断进步。 CRISPR-Cas9等创新技术以及各种基因编辑技术显着提升了对客製化DNA序列的需求。这种需求的激增源于研究人员和生物技术公司对用于实验和应用的精准、特化的DNA构建体的需求，这使得DNA合成成为开创性基因工程倡议的重要组成部分。随着这些先进技术的不断发展，预计各科学领域对客製化DNA合成服务的需求将进一步成长。
限制DNA合成市场的因素
影响DNA合成市场的关键阻碍因素是监管遗传物质合成和应用的严格法律体制。与基因编辑和生物技术相关的严格监管机制可能会阻碍市场准入，并阻碍研发。虽然这些法规对于确保行业内的道德规范和安全至关重要，但它们也可能给该领域的公司带来挑战。因此，遵守这些严格标准的要求可能会减缓创新，并限制DNA合成公司的成长潜力。
DNA合成市场趋势
在基因编辑技术的不断进步推动下，DNA合成市场正经历蓬勃发展，CRISPR-Cas9等工具的出现正在彻底改变这个产业。这项进步显着提升了对客製化DNA序列的需求，而客製化DNA序列对于从治疗方法创新到农业改良等各种应用领域中的精准基因修饰至关重要。随着这些基因编辑解决方案变得更加普及和灵活，它们不仅促进了突破性研究，也正在塑造生物技术的未来。因此，DNA合成市场预计将保持强劲成长，并有望有效满足研究人员和生技公司在寻求变革性解决方案方面不断变化的需求。
目录
介绍
- 调查目标
- 调查范围
- 定义
调查方法
- 资讯收集
- 二手资料和一手资料方法
- 市场规模预测
- 市场假设与限制
执行摘要
- 全球市场展望
- 供需趋势分析
- 细分市场机会分析
市场动态与展望
- 市场规模
- 市场动态
- 驱动因素和机会
- 限制与挑战
- 波特分析
关键市场考察
- 关键成功因素
- 竞争程度
- 关键投资机会
- 市场生态系统
- 市场吸引力指数（2025）
- PESTEL 分析
- 总体经济指标
- 价值链分析
- 定价分析
- 案例研究
- 监管环境
- 专利分析
全球DNA合成市场规模（依产品/服务划分）及复合年增长率（2026-2033年）
- 装置
- 试剂和耗材
- 服务
全球DNA合成市场规模（按类型及复合年增长率划分）（2026-2033年）
- 寡核苷酸合成
- 基因合成
全球DNA合成市场规模（依方法及复合年增长率划分）（2026-2033年）
- 固相合成
- 基于PCR的酶促合成
- 基于晶片的合成
全球DNA合成市场规模（依应用及复合年增长率划分）（2026-2033年）
- 诊断
- 感染疾病
- 癌症
- 治疗药物
- 基因治疗
- 预防医学
- 研究与开发
- 克隆和基因编辑
- 药物发现与开发
全球DNA合成市场规模（依最终用户划分）及复合年增长率（2026-2033年）
- 製药和生物技术公司
- 受託研究机构（CRO）
- 合约研发生产组织（CDMO）
- 学术和研究机构
全球DNA合成市场规模及复合年增长率（2026-2033年）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲
- 中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争资讯
- 前五大公司对比
- 主要企业的市场定位（2025 年）
- 主要市场参与者所采取的策略
- 近期市场趋势
- 公司市占率分析（2025 年）
- 主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- Thermo Fisher Scientific（USA）
- Twist Bioscience（USA）
- BIONEER Corporation（South Korea）
- Eton Bioscience, Inc.（USA）
- LGC Biosearch Technologies（UK）
- IBA Lifesciences GmbH（Germany）
- Eurofins Scientific（Luxembourg）
- Integrated DNA Technologies, Inc.（USA）
- Quintara Biosciences（USA）
- GenScript（China）
- Bio Basic Inc.（Canada）
- OriGene Technologies, Inc.（USA）
- Synbio Technologies（USA）
- GeneArt（Germany）
- Genewiz（USA）
- Sangon Biotech（China）
- Creative Biogene（USA）
- BaseClear BV（Netherlands）
- BioCat GmbH（Germany）
结论与建议
DNA Synthesis Market size was valued at USD 5.31 Billion in 2024 and is poised to grow from USD 6.19 Billion in 2025 to USD 21 Billion by 2033, growing at a CAGR of 16.5% during the forecast period (2026-2033).
The DNA synthesis market is witnessing robust growth, largely fueled by its essential applications in pharmaceuticals, biotechnology, and genetic research. Biotech companies and researchers are increasingly turning to DNA synthesis services to create customized DNA sequences applicable in areas such as drug development and genetic engineering. Key drivers of this market's expansion include the rising need for tools in synthetic biology, the surge in personalized medicine, and ongoing advancements in gene editing technologies. Furthermore, DNA synthesis facilitates rapid prototyping and experimentation, which enhances innovation and accelerates scientific discovery. As the fields of biotechnology and healthcare progress, DNA synthesis is set to play a crucial role in advancing genomics and molecular biology, influencing future developments in these sectors.
Top-down and bottom-up approaches were used to estimate and validate the size of the DNA Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
DNA Synthesis Market Segments Analysis
Global DNA Synthesis Market is segmented by Product, Type, Method, Application, End-user and region. Based on Product, the market is segmented into Instruments, Reagents & Consumables and Services. Based on Type, the market is segmented into Oligonucleotide Synthesis and Gene Synthesis. Based on Method, the market is segmented into Solid-phase Synthesis, PCR-based Enzyme Synthesis and Chip-based Synthesis. Based on Application, the market is segmented into Diagnostics, Therapeutics and Research & Development. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the DNA Synthesis Market
A primary catalyst for the growth of the DNA synthesis market is the ongoing progress in genetic engineering technologies. Innovations such as CRISPR-Cas9 and various gene-editing methodologies have greatly heightened the need for custom DNA sequences. This surge in demand stems from researchers and biotechnology companies seeking accurate and specialized DNA constructs for their experiments and applications, positioning DNA synthesis as an essential element in pioneering genetic engineering initiatives. As these sophisticated technologies continue to evolve, they are expected to further propel the necessity for bespoke DNA synthesis services across diverse scientific fields.
Restraints in the DNA Synthesis Market
A significant constraint affecting the DNA synthesis market is the rigorous regulatory framework governing the synthesis and application of genetic materials. The strict oversight related to gene editing and biotechnology can hinder market accessibility and impede research and development initiatives. While these regulations are crucial for ensuring ethical practices and safety within the industry, they can also present challenges for companies operating in this sector. As a result, the necessity of complying with these stringent standards may delay innovation and restrict the growth potential of businesses involved in DNA synthesis.
Market Trends of the DNA Synthesis Market
The DNA synthesis market is experiencing a dynamic trend fueled by ongoing advancements in gene editing technologies, with tools like CRISPR-Cas9 revolutionizing the landscape. This progress is significantly increasing the demand for customized DNA sequences, essential for precise genetic modifications across diverse applications, from therapeutic innovations to agricultural enhancements. As these gene editing solutions become more accessible and adaptable, they are not only inspiring groundbreaking research but also shaping the future of biotechnology. Consequently, the DNA synthesis market is poised for robust growth, effectively meeting the evolving requirements of researchers and biotech firms striving for transformative solutions.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Case Studies
- Regulatory Landscape
- Patent Analysis
Global DNA Synthesis Market Size by Product & Service & CAGR (2026-2033)
- Market Overview
- Instruments
- Reagents & Consumables
- Services
Global DNA Synthesis Market Size by Type & CAGR (2026-2033)
- Market Overview
- Oligonucleotide Synthesis
- Gene Synthesis
Global DNA Synthesis Market Size by Method & CAGR (2026-2033)
- Market Overview
- Solid-phase Synthesis
- PCR-based Enzyme Synthesis
- Chip-based Synthesis
Global DNA Synthesis Market Size by Application & CAGR (2026-2033)
- Market Overview
- Diagnostics
- Infectious Diseases
- Cancer
- Therapeutics
- Gene Therapy
- Preventive Medicine
- Research & Development
- Cloning and Gene Editing
- Drug Discovery & Development
Global DNA Synthesis Market Size by End-user & CAGR (2026-2033)
- Market Overview
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Contract Development and Manufacturing Organizations (CDMOs)
- Academic & Research Institutes
Global DNA Synthesis Market Size & CAGR (2026-2033)
- North America (Product & Service, Type, Method, Application, End-user)
- US
- Canada
- Europe (Product & Service, Type, Method, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product & Service, Type, Method, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product & Service, Type, Method, Application, End-user)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product & Service, Type, Method, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Twist Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BIONEER Corporation (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eton Bioscience, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LGC Biosearch Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IBA Lifesciences GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integrated DNA Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quintara Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio Basic Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OriGene Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synbio Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GeneArt (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genewiz (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sangon Biotech (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Biogene (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BaseClear B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioCat GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
